VUMC’s ‘Shed-MEDS’ protocol can reduce risk of drug interactions in older people

Vanderbilt University Medical Center’s ‘Shed-MEDS’ protocol may reduce risk drug-drug interactions in older peole.

Researchers clarify role of blood cell mutations in disease

Vanderbilt researchers have developed a new method to analyze mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells.

Discovery of “cross-reactive” antibodies could aid treatment of viral co-infections

Nobel laureate Nurse set for year’s first Discovery Lecture

Nobel Prize-winning geneticist and cell biologist Sir Paul Nurse, PhD, will be at Vanderbilt Thursday, Feb. 9, to deliver the year’s first Discovery Lecture.

Study reveals new genetic disorder that causes susceptibility to opportunistic infections

An international consortium co-led by Vanderbilt’s Rubén Martínez-Barricarte, PhD, has discovered a new genetic disorder that causes immunodeficiency and profound susceptibility to opportunistic infections including a life-threatening fungal pneumonia. 

Study points to new ways to prevent, treat heart disease

Vanderbilt researchers have confirmed the existence of an alternative pathway to atherosclerosis, a finding that may lead to new ways to prevent and treat cardiovascular disease.